ArticleBiomarkers in medicine2018
A peripheral blood transcriptome biomarker test to diagnose functional recovery potential in advanced heart failure.
Article in Biomarkers in medicine, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05258942 (MyLeukoMAP™ Genomic Survival Prediction Assay for Heart Failure Pivotal Clinical Study), which is not on this map. Cited by 8 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
MyLeukoMAP™ Genomic Survival Prediction Assay for Heart Failure Pivotal Clinical Study
Who cites it
8 citing papers in PubMed, 12 citations in OpenAlex.
- Case Report: Exercise-associated changes of leukocyte gene expression in statin-associated myopathy.Frontiers in pharmacology · 2025Article
- Towards identification of postharvest fruit quality transcriptomic markers in Malus domestica.PloS one · 2024Article
- The Role of Gut Microbiota in Heart Failure: When Friends Become Enemies.Biomedicines · 2022Review
- The evolution of patient-specific precision biomarkers to guide personalized heart-transplant care.Expert review of precision medicine and drug development · 2021Article
- Comparing NGS and NanoString platforms in peripheral blood mononuclear cell transcriptome profiling for advanced heart failure biomarker development.Journal of biological methods · 2020Article
- Multi-dimensional COVID-19 short- and long-term outcome prediction algorithm.Expert review of precision medicine and drug development · 2020Article
- Short-Term Therapies for Treatment of Acute and Advanced Heart Failure-Why so Few Drugs Available in Clinical Use, Why Even Fewer in the Pipeline?Journal of clinical medicine · 2019Review
- An exercise immune fitness test to unravel mechanisms of Post-Acute Sequelae of COVID-19.Expert review of clinical immunologyArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author at 1 institution in 1 country.
Funding
Abstract
Heart failure (HF) is a complex clinical syndrome that causes systemic hypoperfusion and failure to meet the body's metabolic demands. In an attempt to compensate, chronic upregulation of the sympathetic nervous system and renin-angiotensin-aldosterone leads to further myocardial injury, HF progression and reduced O
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.